Lepu Biopharma Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
491
- Stock Symbol
-
02157
- Investments
-
6
- Share Price
-
$0.40
- (As of Monday Closing)
Lepu Biopharma General Information
Description
Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.
Contact Information
Website
www.lepubiopharma.comCorporate Office
- No.651, Lianheng Road
- Minhang District
- Shanghai, 201612
- China
Corporate Office
- No.651, Lianheng Road
- Minhang District
- Shanghai, 201612
- China
Lepu Biopharma Timeline
Lepu Biopharma Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.40 | $0.39 | $0.28 - $0.83 | $678M | 1.71B | 2.62M |
Lepu Biopharma Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 810,574 | 921,061 | 1,511,931 | |
Revenue | 28,498 | 31,852 | 2,312 | 0 |
EBITDA | (10,467) | 11,677 | (89,037) | (144,813) |
Net Income | (10,091) | (3,123) | (102,316) | (156,572) |
Total Assets | 335,843 | 336,358 | 366,584 | 326,644 |
Total Debt | 106,611 | 105,355 | 100,054 | 52,598 |
Lepu Biopharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Lepu Biopharma Patents
Lepu Biopharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023220523-A1 | Anti-5t4 antibodies and uses thereof | Pending | 21-Feb-2022 | ||
US-20240247073-A1 | Tumor antigen-dependent cd40 agonists antibodies | Pending | 21-Jan-2022 | ||
US-20240209109-A1 | Tumor antigen-dependent cd40 agonists antibodies | Pending | 21-Jan-2022 | ||
US-20240287208-A1 | Tumor antigen-dependent cd40 agonists antibodies | Pending | 21-Jan-2022 | ||
US-20240182541-A1 | Antibody prodrugs with constant domains | Pending | 23-Aug-2021 | C07K14/7051 |
Lepu Biopharma Signals
Lepu Biopharma Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Lepu Biopharma Investments & Acquisitions (6)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Zenas BioPharma | 07-May-2024 | Drug Discovery | |||
Miracogen | 01-May-2020 | Drug Discovery | |||
KYM Biosciences | 02-Dec-2019 | Drug Discovery | |||
HealSun Biopharm | 09-Aug-2018 | Biotechnology | |||
Binhui Biopharm | 03-Aug-2018 | Later Stage VC | Biotechnology |
Lepu Biopharma Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Miracogen | Drug Discovery | Shanghai, China |
Lepu Biopharma ESG
Risk Overview
Risk Rating
Updated February, 20, 2024
34.05 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Pharmaceuticals
Industry
of 909
Rank
Percentile
Pharmaceuticals
Subindustry
of 446
Rank
Percentile
Lepu Biopharma Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Zenas BioPharma | 07-May-2024 | Completed |
|
Lepu Biopharma FAQs
-
When was Lepu Biopharma founded?
Lepu Biopharma was founded in 2018.
-
Where is Lepu Biopharma headquartered?
Lepu Biopharma is headquartered in Shanghai, China.
-
What is the size of Lepu Biopharma?
Lepu Biopharma has 491 total employees.
-
What industry is Lepu Biopharma in?
Lepu Biopharma’s primary industry is Drug Discovery.
-
Is Lepu Biopharma a private or public company?
Lepu Biopharma is a Public company.
-
What is Lepu Biopharma’s stock symbol?
The ticker symbol for Lepu Biopharma is 02157.
-
What is the current stock price of Lepu Biopharma?
As of 04-Nov-2024 the stock price of Lepu Biopharma is $0.40.
-
What is the current market cap of Lepu Biopharma?
The current market capitalization of Lepu Biopharma is $678M.
-
What is Lepu Biopharma’s current revenue?
The trailing twelve month revenue for Lepu Biopharma is $28.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »